Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
CardiNor enter into a distribution agreement with Demeditec Diagnostics GmbH for the CE marked CardiNor Secretoneurin ELISA test
, /in E-News /by panglobalCardiovascular DX company CardiNor AS today announces that it has signed an exclusive agreement with Demeditec for sales of the CE marked CardiNor Secretoneurin ELISA test in Germany. In addition, the agreement gives Demeditec the right to sell the test, on non-exclusive basis, in 15 countries outside Europe which includes India, South Korea, Mexico and […]
Agilent opens Customer Experience Center highlighting genomics and diagnostics solutions
, /in E-News /by panglobalAgilent Technologies has opened a new Customer Experience Center (CEC) in Lexington, Massachusetts, U.S., focused on solutions from Agilent genomics and diagnostics product portfolios. The facility will serve as a regional hub for Agilent representatives to showcase and demonstrate both product capabilities and complete workflow solutions to customers.
Role of AI in optimizing the whole-slide image acquisition workflow
, /in Featured Articles /by panglobalBy Dr Maria Ada Prusicki Advances in whole-slide scanning technology enabled the automation of microscopy. Researchers can run image acquisition overnight and check the results remotely, minimizing the need for supervision and optimizing their use of time. Nonetheless, a few steps still require intense human supervision, especially for sample identification and scan area definition, where […]
Antibody tests in the management and follow-up of coeliac disease
, /in Featured Articles, Gastrointestinal Disorders /by panglobalby Dr Jacqueline Gosink In 2022, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published a position paper on the management and follow-up of children and adolescents with coeliac disease (CD), following publication of new guidelines for the diagnosis of CD in 2020. This article discusses the different markers that can be used […]
Monitoring of asparaginase activity impacts outcome of children with acute lymphocytic leukemias
, /in Featured Articles /by panglobalby D. K. Cecconello, C. Rechenmacher, Prof. L. E. Daudt and M. B. Michalowski Acute lymphoblastic leukemia is the cancer most commonly found in children and asparaginase (ASNase) is used in the treatment. Our laboratory has been working to establish a regular analysis of ASNase activity in Brazil. Monitoring ASNase activity can be an important […]
Therapeutic drug monitoring for vancomycin: past, present and future
, /in Featured Articles /by panglobalNicole M. Ondrush, PharmD, AAHIVP ; Bryan T. Mogle, PharmD, BCPS Vancomycin remains a mainstay of treatment for invasive infections caused by methicillin-resistant Staphylococcus aureus, and requires therapeutic drug monitoring (TDM) for optimal drug delivery. Herein, we discuss various methods of performing TDM for vancomycin, challenges associated with each method, and future directions for vancomycin […]
The Newborn Genomes Programme: early diagnosis of rare genetic diseases
, /in Featured Articles /by panglobalThere are estimated to be more than 7000 rare genetic diseases (RGDs), which are defined as affecting less than 1 in 2000 people in Europe, many of which are monogenic. Although rare individually, collectively they affect 1 in 50 individuals. Diagnosis of these diseases is often very difficult and patients can remain undiagnosed or diagnosis […]
Ubiquigent collaborates with University of Glasgow on translational structural biology to accelerate drug discovery within the (de)ubiquitylation field
, /in E-News /by panglobalSupporting Master’s student in Prof Helen Walden’s laboratory Project aims to determine USP30 structure to inform the design and discovery of novel inhibitors
Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices
, /in E-News /by panglobalCompany Announces Initiation of Second Phase of Expansion Project
CardiNor enter into a distribution agreement with Demeditec Diagnostics GmbH for the CE marked CardiNor Secretoneurin ELISA test
, /in E-News /by panglobalCardiovascular DX company CardiNor AS today announces that it has signed an exclusive agreement with Demeditec for sales of the CE marked CardiNor Secretoneurin ELISA test in Germany. In addition, the agreement gives Demeditec the right to sell the test, on non-exclusive basis, in 15 countries outside Europe which includes India, South Korea, Mexico and […]